Yifeng Pharmacy (603939.SS) stock: key figures, P/E, revenue and dividend

Consumer Staples · Drug Retail · China · ISIN CNE100001TS5

Price
25.68 CNY
Market cap
31.13 bn CNY
P/E (2025)
18.55
P/S (2025)
1.27
Dividend yield
2.73 %
Net margin
6.87 %
Return on equity (ROE)
13.56 %
Return on assets (ROA)
6.11 %

Yifeng Pharmacy financials

Fiscal year20242025
Revenue24.06 bn CNY24.43 bn CNY
Gross profit9.57 bn CNY9.62 bn CNY
Operating income2.20 bn CNY2.51 bn CNY
EBIT2.22 bn CNY2.62 bn CNY
Net income1.53 bn CNY1.68 bn CNY
Diluted EPS – continuing operations1.24 CNY1.38 CNY

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Yifeng Pharmacy

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. It is also involved in chronic disease management, medical project investment, and medical technology development, as well as operates internet hospitals and clinics. The company also offers its products through franchise distribution and e-commerce. Yifeng Pharmacy Chain Co., Ltd. was founded in 2001 and is headquartered in Changsha, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.

Yifeng Pharmacy stock (603939.SS): P/E, revenue, dividend | finmetric